Open AccessCan Ischemia Modified Albumin Help In Differentiating Myocardial Perfusion Scintigraphy Results?
Author(s) -
Hüseyin Ede,
Barış Yaylak,
Süleyman Akkaya,
Seyhan Karaçavuş,
Ayşe Yeşim Göçmen,
Ali Rıza Erbay
Publication year - 2016
Publication title -
türk kardiyoloji derneği arşivi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 24
ISSN - 1016-5169
DOI - 10.5543/tkda.2016.99148
Subject(s) - medicine , ischemia modified albumin , ischemia , myocardial perfusion scintigraphy , scintigraphy , perfusion , cardiology , bruce protocol , myocardial ischemia , coronary angiography , myocardial infarction , heart rate , blood pressure
Myocardial perfusion scintigraphy (MPS) is a diagnostic tool commonly used to detect significant coronary lesion. However equivocal, false negative or positive results can be yielded. Controversial findings regarding the role of ischemia-modified albumin (IMA) in MPS evaluation persist. The aim of the present study was to examine the role of serum IMA in the assessment of MPS results.